These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12519876)

  • 21. Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.
    Klemke M; Drieschner N; Belge G; Burchardt K; Junker K; Bullerdiek J
    Genes Chromosomes Cancer; 2012 Apr; 51(4):402-8. PubMed ID: 22179975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
    Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
    Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.
    Fabbro D; Di Loreto C; Beltrami CA; Belfiore A; Di Lauro R; Damante G
    Cancer Res; 1994 Sep; 54(17):4744-9. PubMed ID: 8062273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPARgamma staining as a surrogate for PAX8/PPARgamma fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value.
    Sahin M; Allard BL; Yates M; Powell JG; Wang XL; Hay ID; Zhao Y; Goellner JR; Sebo TJ; Grebe SK; Eberhardt NL; McIver B
    J Clin Endocrinol Metab; 2005 Jan; 90(1):463-8. PubMed ID: 15483076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.
    Boos LA; Dettmer M; Schmitt A; Rudolph T; Steinert H; Moch H; Sobrinho-Simões M; Komminoth P; Perren A
    Histopathology; 2013 Aug; 63(2):234-41. PubMed ID: 23738683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-trans-retinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1.
    Kurebayashi J; Tanaka K; Otsuki T; Moriya T; Kunisue H; Uno M; Sonoo H
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2889-96. PubMed ID: 10946899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low frequency of PAX8-PPARγ rearrangement in follicular thyroid carcinomas in Japanese patients.
    Mochizuki K; Kondo T; Oishi N; Tahara I; Inoue T; Kasai K; Nakazawa T; Okamoto T; Shibata N; Katoh R
    Pathol Int; 2015 May; 65(5):250-3. PubMed ID: 25708358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.
    Foukakis T; Au AY; Wallin G; Geli J; Forsberg L; Clifton-Bligh R; Robinson BG; Lui WO; Zedenius J; Larsson C
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1143-9. PubMed ID: 16352687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid.
    Klemke M; Drieschner N; Laabs A; Rippe V; Belge G; Bullerdiek J; Sendt W
    Cancer Genet; 2011 Jun; 204(6):334-9. PubMed ID: 21763631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic binding of PAX8-PPARG fusion protein regulates cancer-related pathways and alters the immune landscape of thyroid cancer.
    Zhang Y; Yu J; Grachtchouk V; Qin T; Lumeng CN; Sartor MA; Koenig RJ
    Oncotarget; 2017 Jan; 8(4):5761-5773. PubMed ID: 28008156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathogenesis of differentiated thyroid cancer (papillary and follicular)].
    Maciel RM; Kimura ET; Cerutti JM
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):691-700. PubMed ID: 16444351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.
    Batista FA; Ward LS; Marcello MA; Martins MB; Peres KC; Torricelli C; Bufalo NE; Soares FA; da Silva MJ; Assumpção LV
    J Endocrinol Invest; 2016 Apr; 39(4):423-9. PubMed ID: 26370671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.
    Algeciras-Schimnich A; Milosevic D; McIver B; Flynn H; Reddi HV; Eberhardt NL; Grebe SK
    Clin Chem; 2010 Mar; 56(3):391-8. PubMed ID: 20056739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
    Reddi HV; McIver B; Grebe SK; Eberhardt NL
    Endocrinology; 2007 Mar; 148(3):932-5. PubMed ID: 16946003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
    Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
    Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX8PPARgamma stimulates cell viability and modulates expression of thyroid-specific genes in a human thyroid cell line.
    Espadinha C; Cavaco BM; Leite V
    Thyroid; 2007 Jun; 17(6):497-509. PubMed ID: 17614769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.
    Armstrong MJ; Yang H; Yip L; Ohori NP; McCoy KL; Stang MT; Hodak SP; Nikiforova MN; Carty SE; Nikiforov YE
    Thyroid; 2014 Sep; 24(9):1369-74. PubMed ID: 24798894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Gene abnormalities in thyroid cancer].
    Namba H; Yamashita S
    Nihon Rinsho; 2007 Nov; 65(11):1967-72. PubMed ID: 18018556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.